BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of 97.99 million. The enterprise value is 83.91 million.
| Market Cap | 97.99M |
| Enterprise Value | 83.91M |
Important Dates
The last earnings date was Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
| Current Share Class | 11.26M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.47% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.59M |
Valuation Ratios
The trailing PE ratio is 16.18.
| PE Ratio | 16.18 |
| Forward PE | n/a |
| PS Ratio | 3.38 |
| PB Ratio | 3.55 |
| P/TBV Ratio | 4.06 |
| P/FCF Ratio | 11.22 |
| P/OCF Ratio | 11.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.23, with an EV/FCF ratio of 9.61.
| EV / Earnings | 13.86 |
| EV / Sales | 2.93 |
| EV / EBITDA | 10.23 |
| EV / EBIT | 10.81 |
| EV / FCF | 9.61 |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.07 |
| Quick Ratio | 5.00 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.08 |
| Interest Coverage | 197.21 |
Financial Efficiency
Return on equity (ROE) is 22.62% and return on invested capital (ROIC) is 17.82%.
| Return on Equity (ROE) | 22.62% |
| Return on Assets (ROA) | 15.75% |
| Return on Invested Capital (ROIC) | 17.82% |
| Return on Capital Employed (ROCE) | 27.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.93 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, BioSyent has paid 2.10 million in taxes.
| Income Tax | 2.10M |
| Effective Tax Rate | 25.78% |
Stock Price Statistics
The stock price has increased by +12.52% in the last 52 weeks. The beta is 0.36, so BioSyent's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +12.52% |
| 50-Day Moving Average | 8.47 |
| 200-Day Moving Average | 8.05 |
| Relative Strength Index (RSI) | 58.53 |
| Average Volume (20 Days) | 2,242 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of 28.97 million and earned 6.06 million in profits. Earnings per share was 0.52.
| Revenue | 28.97M |
| Gross Profit | 22.65M |
| Operating Income | 7.85M |
| Pretax Income | 8.16M |
| Net Income | 6.06M |
| EBITDA | 8.20M |
| EBIT | 7.85M |
| Earnings Per Share (EPS) | 0.52 |
Balance Sheet
The company has 14.93 million in cash and 690,857 in debt, giving a net cash position of 14.24 million.
| Cash & Cash Equivalents | 14.93M |
| Total Debt | 690,857 |
| Net Cash | 14.24M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 27.57M |
| Book Value Per Share | 2.45 |
| Working Capital | 18.73M |
Cash Flow
In the last 12 months, operating cash flow was 8.78 million and capital expenditures -43,946, giving a free cash flow of 8.73 million.
| Operating Cash Flow | 8.78M |
| Capital Expenditures | -43,946 |
| Free Cash Flow | 8.73M |
| FCF Per Share | n/a |
Margins
Gross margin is 78.18%, with operating and profit margins of 27.10% and 20.90%.
| Gross Margin | 78.18% |
| Operating Margin | 27.10% |
| Pretax Margin | 28.16% |
| Profit Margin | 20.90% |
| EBITDA Margin | 28.29% |
| EBIT Margin | 27.10% |
| FCF Margin | 30.15% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 1.59%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 1.59% |
| Dividend Growth (YoY) | 7.85% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 26.16% |
| Buyback Yield | 2.47% |
| Shareholder Yield | 4.06% |
| Earnings Yield | 6.18% |
| FCF Yield | 8.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSyent has an Altman Z-Score of 16.17 and a Piotroski F-Score of 5.
| Altman Z-Score | 16.17 |
| Piotroski F-Score | 5 |